186 related articles for article (PubMed ID: 32593612)
1. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
2. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
3. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
4. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
[TBL] [Abstract][Full Text] [Related]
5. Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.
Ellison M; Haberlandt C; Gomez-Casati ME; Watkins M; Elgoyhen AB; McIntosh JM; Olivera BM
Biochemistry; 2006 Feb; 45(5):1511-7. PubMed ID: 16445293
[TBL] [Abstract][Full Text] [Related]
6. Key residues in the nicotinic acetylcholine receptor β2 subunit contribute to α-conotoxin LvIA binding.
Zhangsun D; Zhu X; Wu Y; Hu Y; Kaas Q; Craik DJ; McIntosh JM; Luo S
J Biol Chem; 2015 Apr; 290(15):9855-62. PubMed ID: 25713061
[TBL] [Abstract][Full Text] [Related]
7. A novel α4/7-conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Schroeder CI; Zhu X; Hu Y; Wu Y; Weltzin MM; Eberhard S; Kaas Q; Craik DJ; McIntosh JM; Whiteaker P
FASEB J; 2014 Apr; 28(4):1842-53. PubMed ID: 24398291
[TBL] [Abstract][Full Text] [Related]
8. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.
Azam L; McIntosh JM
J Neurochem; 2012 Sep; 122(6):1137-44. PubMed ID: 22774872
[TBL] [Abstract][Full Text] [Related]
11. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
Jiang S; Tae HS; Xu S; Shao X; Adams DJ; Wang C
Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28598389
[TBL] [Abstract][Full Text] [Related]
13. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
[TBL] [Abstract][Full Text] [Related]
14. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
15. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
[TBL] [Abstract][Full Text] [Related]
16. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
17. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
18. α-Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes.
Ning H; Huang B; Tae HS; Liu Z; Yu S; Li L; Zhang L; Adams DJ; Guo C; Dai Q
J Neurochem; 2021 Oct; 159(1):90-100. PubMed ID: 34008858
[TBL] [Abstract][Full Text] [Related]
19. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
20. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]